Pfizer Inc. closed 18.77% short of its 52-week high of $31.54, which the company achieved on July 30th.

Moderna shares surged 9.5% amid legal backlash against vaccine policy changes. Will it be a turning point for MRNA which is struggling with weaker sales?

The American Academy of Pediatrics, the American College of Physicians and four other major national public health groups ...